Literature DB >> 26100186

Overdiagnosis of thyroid cancer: answers to five key questions.

Jenny K Hoang1, Xuan V Nguyen2, Louise Davies3.   

Abstract

Thyroid cancer fulfills the criteria for overdiagnosis by having a reservoir of indolent cancers and practice patterns leading to the diagnosis of incidental cancers from the reservoir. The occurrence of overdiagnosis is also supported by population-based data showing an alarming rise in thyroid cancer incidence without change in mortality. Because one of the activities leading to overdiagnosis is the workup of incidental thyroid nodules detected on imaging, it is critical that radiologists understand the issue of overdiagnosis and their role in the problem and solution. This article addresses 1) essential thyroid cancer facts, 2) the evidence supporting overdiagnosis, 3) the role of radiology in overdiagnosis, 4) harms of overdiagnosis, and 5) steps radiologists can take to minimize the problem.
Copyright © 2015 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Thyroid cancer; incidental thyroid nodule; incidentaloma; overdiagnosis; screening

Mesh:

Year:  2015        PMID: 26100186     DOI: 10.1016/j.acra.2015.01.019

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  22 in total

1.  Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes.

Authors:  Amanda K Price; Reese W Randle; David F Schneider; Rebecca S Sippel; Susan C Pitt
Journal:  J Surg Res       Date:  2017-06-21       Impact factor: 2.192

Review 2.  Thyroid cancer surgery guidelines in an era of de-escalation.

Authors:  K J Kovatch; C W Hoban; A G Shuman
Journal:  Eur J Surg Oncol       Date:  2017-03-16       Impact factor: 4.424

3.  Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules.

Authors:  Naykky M Singh Ospina; Diliara Bagautdinova; Ian Hargraves; Diana Barb; Sreevidya Subbarayan; Ashok Srihari; Shu Wang; Spyridoula Maraka; Carma L Bylund; Debbie Treise; Victor Montori; Juan P Brito
Journal:  Clin Endocrinol (Oxf)       Date:  2021-09-29       Impact factor: 3.478

4.  Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression.

Authors:  Bo Chen; Deqing Liu; Runjie Chen; Libing Guo; Jianmin Ran
Journal:  Discov Oncol       Date:  2022-07-01

Review 5.  Importance of cost-effectiveness and value in cancer care and healthcare policy.

Authors:  Ravinder Kang; Philip P Goodney; Sandra L Wong
Journal:  J Surg Oncol       Date:  2016-06-22       Impact factor: 3.454

6.  Plasma ω-3 and ω-6 fatty acids in thyroid diseases.

Authors:  Xiang Li; Hui Li; Jing Zhao; Qi Dai; Chaoran Huang; Langping Jin; Fan Yang; Fuxue Chen; Ouchen Wang; Ying Gao
Journal:  Oncol Lett       Date:  2018-08-09       Impact factor: 2.967

7.  Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1.

Authors:  Deborah Fanfone; Nadège Despretz; Dimitri Stanicki; Jenifer Rubio-Magnieto; Mathieu Fossépré; Mathieu Surin; Sandrine Rorive; Isabelle Salmon; Luce Vander Elst; Sophie Laurent; Robert N Muller; Sven Saussez; Carmen Burtea
Journal:  Med Oncol       Date:  2017-10-06       Impact factor: 3.064

8.  Hypermethylation of microRNA-497-3p contributes to progression of thyroid cancer through activation of PAK1/β-catenin.

Authors:  Yuxia Fan; Xin Fan; Hao Yan; Zheng Liu; Xiaoming Wang; Qingling Yuan; Jie Xie; Xiubo Lu; Yang Yang
Journal:  Cell Biol Toxicol       Date:  2022-01-23       Impact factor: 6.691

9.  Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.

Authors:  Alexandria D McDow; Benjamin R Roman; Megan C Saucke; Catherine B Jensen; Nick Zaborek; Jamia Linn Jennings; Louise Davies; Juan P Brito; Susan C Pitt
Journal:  Am J Surg       Date:  2020-11-12       Impact factor: 3.125

10.  Classification of Benign and Malignant Thyroid Nodules Using a Combined Clinical Information and Gene Expression Signatures.

Authors:  Bing Zheng; Jun Liu; Jianlei Gu; Jing Du; Lin Wang; Shengli Gu; Juan Cheng; Jun Yang; Hui Lu
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.